[Des-Tyr1] b-Endorphin, human lacks the initial aromatic residue, shifting N-terminal charge distribution and structural preferences. The modification provides an effective tool for dissecting intramolecular contacts in endorphin peptides. Researchers utilize it to investigate sequence contributions to flexibility and recognition motifs. Its properties support comparative studies across neuropeptide families.
CAT No: E05021
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.